Residual symptoms in patients with partial versus complete remission of a major depressive disorder episode: patterns of painful physical symptoms in depression

被引:15
|
作者
Harada, Eiji [1 ]
Satoi, Yoichi [2 ]
Kikuchi, Toshiaki [3 ]
Watanabe, Koichiro [3 ]
Alev, Levent [1 ]
Mimura, Masaru [4 ]
机构
[1] Eli Lilly Japan KK, Med Dev Unit Japan, Med Sci, Kobe, Hyogo 6510086, Japan
[2] Eli Lilly Japan KK, Stat Sci, Med Dev Unit Japan, Kobe, Hyogo 6510086, Japan
[3] Kyorin Univ, Sch Med, Dept Neuropsychiat, Mitaka, Tokyo, Japan
[4] Keio Univ, Sch Med, Dept Neuropsychiat, Tokyo, Japan
关键词
major depressive disorder; residual symptoms; partial remission; complete remission; painful physical symptoms; pain; depression; COMORBIDITY;
D O I
10.2147/NDT.S102767
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: The patterns of residual painful physical symptoms (PPS) and emotional symptoms among patients with partial remission (PR) or complete remission (CR) of a major depressive disorder (MDD) episode were compared. Methods: This is a multicenter, cross-sectional, observational study. Patients who had originally been diagnosed with MDD, were treated with an antidepressant for 12 weeks for that episode, and achieved either PR or CR at study entry were enrolled in the study. Using the 17-item Hamilton Rating Scale for Depression (HAM-D17), PR was defined as a score of >= 8 and <= 18 and CR as a score of <= 7. Residual symptoms were assessed using the Brief Pain Inventory-Short Form (BPI-SF) and the HAM-D17. Results: A total of 323 patients (CR = 158, PR = 165) were included in the study. Patients in the PR group had a higher mean (standard deviation) score in the HAM-D17 than those in the CR group (11.8 [3.1] and 4.4 [2.0], respectively). BPI-SF results showed that "at least moderate PPS" (score >= 3 on BPI-SF question 5) was significantly more prevalent among patients with PR than those with CR (37.0% vs 16.5%, respectively; odds ratio =3.04; P < 0.001). Presence of pain (any severity) was also more prevalent among patients with PR than those with CR (54.5% vs 35.4%, respectively). The HAM-D17 results for individual items indicated that impaired work and activities, depressed mood, psychological and somatic anxiety, and general somatic symptoms were observed in at least 75% of patients with PR. Conclusion: PR was associated with a higher prevalence of at least moderate PPS. Other residual symptoms commonly observed in patients with PR included typical core emotional symptoms (eg, loss of interest, depressed mood, and psychological anxiety). These results underline the importance of PPS, because PPS is clinically relevant for the patients but difficult to assess with the commonly used depression evaluation scale.
引用
收藏
页码:1599 / 1607
页数:9
相关论文
共 50 条
  • [31] Cognitive impairment in major depressive disorder and severe depressive episode with psychotic symptoms
    Fedorova, S.
    Blazkova, M.
    Humpolicek, P.
    Bartecek, R.
    EUROPEAN PSYCHIATRY, 2017, 41 : S143 - S144
  • [32] Comparison of duloxetine and SSRI as a treatment option of painful physical symptoms associated with major depressive disorder
    Haider, Miqdad
    Shafqat, Muhammad Nabeel
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2017, 13 : 2505 - 2506
  • [33] Painful physical symptoms in hospitalized patients with acute depressive episode: results from a naturalistic study
    Nikolina, Rijavec
    Virginija, Novak Grubic
    ZDRAVNISKI VESTNIK-SLOVENIAN MEDICAL JOURNAL, 2013, 82 (02): : 93 - 98
  • [34] Painful physical symptoms and treatment outcome in major depressive disorder: a STAR*D (Sequenced Treatment Alternatives to Relieve Depression) report
    Leuchter, A. F.
    Husain, M. M.
    Cook, I. A.
    Trivedi, M. H.
    Wisniewski, S. R.
    Gilmer, W. S.
    Luther, J. F.
    Fava, M.
    Rush, A. J.
    PSYCHOLOGICAL MEDICINE, 2010, 40 (02) : 239 - 251
  • [35] Efficacy of vortioxetine on the physical symptoms of major depressive disorder
    Christensen, Michael Cronquist
    Florea, Ioana
    Lindsten, Annika
    Baldwin, David S.
    JOURNAL OF PSYCHOPHARMACOLOGY, 2018, 32 (10) : 1086 - 1097
  • [36] Predictors of the Onset of Manic Symptoms and a (Hypo)Manic Episode in Patients with Major Depressive Disorder
    Boschloo, Lynn
    Spijker, Annet T.
    Hoencamp, Erik
    Kupka, Ralph
    Nolen, Willem A.
    Schoevers, Robert A.
    Penninx, Brenda W. J. H.
    PLOS ONE, 2014, 9 (09):
  • [37] Effect of CPAP treatment on residual depressive symptoms in patients with major depression and coexisting sleep apnea: Contribution of daytime sleepiness to residual depressive symptoms
    Habukawa, Mitsunari
    Uchimura, Naohisa
    Kakuma, Tatsuyuki
    Yamamoto, Katsuyasu
    Ogi, Kimihiro
    Hiejima, Hiroshi
    Tomimatsu, Kentaro
    Matsuyama, Seiichiro
    SLEEP MEDICINE, 2010, 11 (06) : 552 - 557
  • [38] The Relationship Between Depression Symptoms and Anxiety Symptoms During Acute ECT for Patients With Major Depressive Disorder
    Huang, Chun-Jen
    Lin, Ching-Hua
    Wu, Jyh-I
    Yang, Wei-Cheng
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2019, 22 (10): : 609 - 615
  • [39] Residual Symptoms in Major Depressive Disorder: Prevalence, Effects, and Management
    Zajecka, John
    Kornstein, Susan G.
    Blier, Pierre
    JOURNAL OF CLINICAL PSYCHIATRY, 2013, 74 (04) : 407 - 414
  • [40] RESIDUAL SYMPTOMS IN MAJOR DEPRESSIVE DISORDER: CLINICAL UTILITY OF VENLAFAXINE
    Purushottamahanti, Pradeep
    Mcintyre, Roger
    Agid, Ofer
    Biesheuvel, Egbert
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2025, 28 : I313 - I314